Loading...
Curcumin as an anticancer agent in malignant mesothelioma: A review
Baldi, A De Luca, A Maiorano, P D’angelo, C Giordano, A
Baldi, A
De Luca, A
Maiorano, P
D’angelo, C
Giordano, A
Citations
Altmetric:
Genre
Review
Journal
Journal
Date
2020-03-01
Advisor
Committee member
Group
Department
Subject
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
10.3390/ijms21051839
Abstract
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. Malignant mesothelioma is an infrequent tumor that initiates from the mesothelial cells lining of body cavities. The great majority of mesotheliomas originate in the pleural cavity, while the remaining cases initiate in the peritoneal cavity, in the pericardial cavity or on the tunica vaginalis. Usually, mesotheliomas grow in a diffuse pattern and tend to enclose and compress the organs in the various body cavities. Mesothelioma incidence is increasing worldwide and still today, the prognosis is very poor, with a reported median survival of approximately one year from presentation. Thus, the development of alternative and more effective therapies is currently an urgent requirement. The aim of this review article was to describe recent findings about the anti-cancer activity of curcumin and some of its derivatives on mesotheliomas. The potential clinical implications of these findings are discussed.
Description
Citation
Citation to related work
MDPI AG
Has part
International Journal of Molecular Sciences
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu